Disclosure Panels Details Page

Hepatobiliary Cancers Panel - Disclosures as of 09/27/2018

Panel Member
(Spouse/Domestic Partner/Dependent)
Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Has Attended
Daniel Abbott MD None None None None
Thomas Abrams MD None Aduro Biosciences
Bayer HealthCare
Bristol Myers Squibb
Kaleido Biosciences
Exelixis Inc. None -
Steven Alberts MD, MPH None None None None -
Daniel Anaya MD None None None None -
Robert Anders MD, PhD None Bristol Myers Squibb
Merck & Co., Inc.
None None
Chandrakanth Are MBBS, MBA, FACS, FRCS None None None None -
Al Benson III MD, FACCC, FACP, FASCO None Astellas Pharma US, Inc.
Bayer HealthCare
Bristol Myers Squibb
Eli Lilly and Company
Exelixis Inc.
Genentech, Inc.
Merck & Co., Inc.
Purdue Pharma LP
None None
Marian Birkeland PhD None None None None -
Daniel Brown MD, FSIR Sirtex Medical BTG Bard Medical None -
Daniel Chang MD Varian Medical Systems, Inc. None None None
Jordan Cloyd MD None None None None
Alycia Corrigan None None None None -
Anne Covey MD None None Accurate Medical None
Michael D'Angelica MD None None None None
Susan Darlow PhD None None None None
Sarah DeVincenzo PharmD, BCPS None Decision Resources Group Consulting None None -
Kristina Gregory MSN, RN None None None None -
Lydia Hammond MBA None None None Merck & Co., Inc.
Evelyn Handel PharmD, BCOP, BCPS None None None None -
William Hawkins MD Accuronix None Accuronix therapeutics None
Renuka Iyer MD None Bayer HealthCare
Eisai Inc.
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
None None -
Rojymon Jacob MD Novocure None Medtronic, Inc.
Novocure
Varian Medical Systems, Inc.
None -
Andreas Karachristos MD None None None None -
Ann Karosas RPh, BCOP None None None None -
Robin Kelley MD Adaptimmune
Agios, Inc.
AstraZeneca Pharmaceuticals LP
Bayer HealthCare
Bristol Myers Squibb
Eli Lilly and Company
Exelixis Inc.
Genentech, Inc.
MedImmune Inc.
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Taiho Pharmaceuticals Co., Ltd.
Agios, Inc.
AstraZeneca Pharmaceuticals LP
Bayer HealthCare
Bristol Myers Squibb
Exelixis Inc.
TargetPharma Solutions
None None
Robin Kim MD None None None None -
Manisha Palta MD None None Merck & Co., Inc.
Navigant
OAKSTONE CME
UptoDate
None -
James Park MD None None None None -
Sharon Park PharmD, BCOP None None None None -
Donna Powell DHSc, CMD, RT(T) None None None None -
Vaibhav Sahai MBBS, MS Agios, Inc.
Bristol Myers Squibb
Celgene Corporation
Incyte Corporation
Merck & Co., Inc.
NewLink Pharmaceuticals
Celgene Corporation
Halozyme Pharmaceuticals
None None
Tracey Schefter MD None None None None
Jason Sicklick MD Foundation Medicine, Inc.
Novartis Pharmaceuticals Corporation
CarsGen Therapeutics
Grand Rounds
Loxo Oncology
None None -
Gagandeep Singh MD None None None None
Jack Skinner PhD None None None None -
Davendra Sohal MD, MPH None Foundation Medicine
Perthera
None None
Stacey Stein MD None Genentech, Inc.
Merck & Co., Inc.
None None
Gary Tian MD, PhD, FACP None Axess Oncology
Cardinal Health
Exelixis Inc.
Incyte Corporation
Janssen Pharmaceutica Products, LP
Merck & Co., Inc.
None None
Jean-Nicolas Vauthey MD None None None None -
Alan Venook MD Halozyme, Inc. AstraZeneca Pharmaceuticals LP
Eisai Inc.
Genentech, Inc.
Roche Laboratories, Inc.
Taiho Pharmaceuticals Co., Ltd.
None None
Andrew Zhu MD, PhD None Bristol Myers Squibb
Eisai Inc.
Merck & Co., Inc.
Bayer HealthCare Bristol Myers Squibb|Eli Lilly and Company -